Overexpression of the TCL1 gene family plays a role in the onset of T-cell leukemias in mice and in humans. The Tcl1 gene is tightly regulated during early embryogenesis in which it participates in embryonic stem (ES)-cells proliferation and during lymphoid differentiation. Here, we provide evidences that Tcl1 is also important in mouse hair follicle (HF) and skin homeostasis. We found that Tcl1 À/À adult mice exhibit hair loss, leading to alopecia with extensive skin lesions. By analysing Tcl1 expression in the wild-type (wt) skin through different stages of hair differentiation, we observe high levels in the secondary hair germ (HG) cells and hair bulges, during early anagen and catagen-telogen transition phases. The loss of Tcl1 does not result in apparent skin morphological defects during embryonic development and at birth, but its absence causes a reduction of proliferation in anagen HFs. Importantly, we show the that absence of Tcl1 induces a significant loss of the stem-cell marker CD34 (but not a6-integrin) expression in the bulge cells, which is necessary to maintain stem-cell characteristics. Therefore, our findings indicate that Tcl1 gene(s) might have important roles in hair formation, by its involvement in cycling and self-renewal of transient amplifying (TA) and stem-cell (SC) populations.
Introduction
The T-cell leukemia/lymphoma 1 (TCL1) gene has been primarily identified for its involvement in human T-prolymphocytic leukemia (T-PLL). Here, a reciprocal translocation of TCL1 locus at 14q32 causes the juxtaposition to T-cell-receptor enhancers, leading to TCL1 ectopic overexpression (Russo et al., 1988; Virgilio et al., 1994) . Thus, TCL1 contributes to T-PLL by increasing cell proliferation and/or cell survival. Three transgenic mouse models carrying TCL1 under the control of T-and B-cell promoters develop mature T-and B-cell leukemia, thus confirming the oncogenic role of TCL1 overexpression (Virgilio et al., 1998; Bichi et al., 2002; Hoyer et al., 2002) . Moreover, TCL1 has been shown to be constitutively expressed in a tightly regulated manner in lymphoid cells of B and T origins (Narducci et al., 1997a, b; Takizawa et al., 1998; Teitell et al., 1999; Kang et al., 2005) . Functionally, Tcl1 exerts its function by binding the pleckstrin domain of AKT proteins, thereafter increasing AKT kinase activity and enhancing AKT nuclear translocation in vitro (Laine et al., 2000; Pekarsky et al., 2000; Kunstle et al., 2002) and in vivo (Zanesi et al., 2006) . In particular, the presence of Tcl1 allows the serine-473 transphosphorylation of AKT proteins in the oligomeric complex, thus ensuring maximal kinase activity and facilitating an amplification loop of the antiapoptotic, proliferative stimuli controlled by the PI3-kinase-AKT pathway . More recently, TCL1 has been shown to also bind another type of PH domain (of the PNPase exoribonuclease) (French et al., 2006) . Furthermore, the study of Tcl1 in murine systems has shown that Tcl1 is expressed in the ovary, testis and preimplantation embryos (Hallas et al., 1999; Narducci et al., 1997a Narducci et al., , b, 2002 and in murine embryonic stem (ES) cells (Ivanova et al., 2006) . In particular, it plays an important role in the latter as, in Tcl1 À/À mice, preimplantation embryos are not able to progress beyond the 4-cell stage, in vitro (Narducci et al., 2002) . In ES cells, Tcl1 acts in proliferation and normal self-renewal under the direct activation of OCT3/4, Zfx and KLF5 transcription factors (Matoba et al., 2006; Galan-Caritad et al., 2007; Ema et al., 2008) . Therefore, Tcl1 is not ubiquitously expressed, but seems to be tightly regulated in cells that undergo different waves of proliferative signals to complete their differentiation programs: pro-B cells in the bone marrow, the mantle lymphocytes of peripheral lymph nodes in which B cells must encounter the antigen and go through new waves of mitosis, the fertilized egg before zygotic gene activation when the cell, still under maternal control, must divide rapidly after having been blocked in metaphase II for a long time and ES cells.
Since we made Tcl1 À/À mice more than 5 years ago, we have observed that the Tcl1 À/À mice, other than the lymphoid and embryonic non-lethal phenotypes (Narducci et al., 2002 , Kang et al., 2005 , show a skin defect in adults with the onset of alopecia followed by skin wounding. As the epidermis provides a model tissue to investigate proliferation and self-renewal mechanisms, particular attention has been focused on hair follicles (HFs) as they go through cyclic regeneration that comprises degenerative (catagen), resting (telogen) and regenerative (anagen) phases (Stenn and Paus, 2001) . The bulge cells that reside in the HFs are assumed to be the stem cells that drive the HF regeneration and epidermal repair. Bulge cells express high levels of CD34 Tumbar et al., 2004) , a well known stem-cell marker of either hematopoietic or HF.
Here we provide the expression pattern of Tcl1 in the mouse skin and an initial first insight into the molecular consequences of Tcl1 loss of function, in this compartment. These findings indicate that Tcl1 has a role in the maintenance of a normal skin homeostasis in mice, involving both hair growth and epidermis.
Results

Tcl1
À/À mice develop alopecia and skin impairment: macroscopical and histopathological analysis Tcl1 À/À mice show no gross histological or physical abnormality at birth, except a fertility defect and a mild impairment of the immune system in adult life (Kang et al., 2005; Narducci et al., 1997a Narducci et al., , b, 2002 . These mice develop a form of mild alopecia starting from the head and neck region (Figure 1, Supplementary Figures S1  and S2 ). The onset of this alopecia is variable, but we never observe any phenotype before 2 months of age. This phenotype result remains constant throughout the years. Histological assessment of the affected regions with respect to pre-alopecic condition (Figure 1b) shows atrophy of the HFs, that is blocked at the telogen ( Figure 1c ) and hypertrophy of epidermis with focal localization (not shown). Thereafter, the alopecia expands and the mice start to show a progressive impairment of the skin tissue (Supplementary Figure  S2) . The phenotype is rescued when deficient Tcl1 À/À mice are crossed to overexpressing TCL1 under keratin 14 promoter (K14-TCL1; Tcl1 À/À ); these mice never show alopecia and skin damages (Figure 1d ).
Skin impairment shows up at around 6 months of age, starting from regions with hair loss. Histological assessment at this time, shows deep-dermal infiltration by lymphocytes, plasma cells, eosinophils and mast cells, with macrophages containing phagocytized melanotic pigment (incontinentia pigmenti), because of continuous damage to the basal layer of the epidermis that becomes extensively hypertrophic. Later on, as the infiltrate intensifies, ulcers and hyperplastic reparative modification of the epidermis and degeneration of subdermal fat tissue, because of severe fibrosis with infiltration of inflammatory cells (Figures 1e-f) , appear in Tcl1 À/À mice compared with normal mice. The peak of the onset of the skin lesions is between the ages of eleven (12,58% of Tcl1 À/À ) and fourteen months (62,3% of Tcl1
À/À mice (twenty months old) show this phenotype.
Tcl1 is expressed in normal epidermal tissue and its pattern is mainly restricted to early anagen and catagen-telogen transition phases of HF These observations prompted us to investigate whether Tcl1 is expressed in the wild-type (wt) mouse skin. We carried out reverse transcriptase-PCR analysis for Tcl1 on wt RNA extracted from the dorsal skins of 6-weeks-old mice, 1, 3, 6 and 8 days after depilation, corresponding to synchronised early anagen stages I, II, III and IV of the HF development and skin differentiation (Panteleyev et al., 2000) . The anagen phase involves the complete re-growth and regeneration of the cycling portion of HF. In all the examined samples, we found a Tcl1-specific transcript (Figure 2a ), meaning that Tcl1 is expressed in the early anagen stages in wts.
To investigate whether the expression of Tcl1 is cell-cycle and/or HF-phase dependent, we carried out immunohistochemistry, immunofluorescence and in situ hybridization (with fluorescent mRNA probe) on 6-weeks-old wt mice skin longitudinal sections at 1, 3, 5, 8, (anagen I to IV), 18, 21 (catagen), 22 (catagentelogen) , 23 and 24 (telogen) days after depilation. In the epidermis, we found that Tcl1 is continuously, although very weakly, expressed in all the examined stages ( Figure 2b , example at 8 days after depilation). In this case, Tcl1 staining is detectable mainly by chemical, but not by fluorescent, labeling also because of autofluorescence of the epidermal layers in our experimental conditions. In the HFs, the expression is time restricted at day 3, and from days 22 to 24 after depilation corresponding, respectively, to early anagen (anagen II, proliferating phase of HF) and to late catagen-early telogen phases (the regressing-resting phases of HF) (Muller-Rover et al., 2001) . In anagen II, Tcl1 is observed almost exclusively in the region of the outer root sheath of the HF corresponding to the bulge (Figures 2c-e) , in which HF stem-cells have been described Ito et al., 2004; Tumbar et al., 2004) .
In catagen-telogen phases, the expression pattern of Tcl1 is more dynamic. In particular, although undetectable at day 21 (not shown), at day 22 post-depilation we observe a strong labeling in the bulge (Figure 2f ), with also a weak expression of Tcl1 in the epithelial strand. The epithelial strand, known to be a regressing structure, contains progenitor cells called secondary hair germ (HG) cells that are able to proliferate in response to growth signaling. At day 23-post-depilation, the expression becomes stronger in these cells, and is maintained in the bulge (Figure 2g ). Later on, at day 24 post-depilation, as the expression in the regressed epithelial strand reaches its maximum, the bulgelabeling decreases ( Figure 2h) ; a definite border is visible between the labeled epithelial strand and the unlabeled dermal papilla. No expression of Tcl1 is observed in Tcl1 À/À mice (not shown).
Tcl1B2, another member of the Tcl1 family is expressed in the HF Although Tcl1 seems to be an important molecular marker for at least two distinct cell populations in the HF (the bulge cells and the secondary HG-cells), the late onset and the apparent absence of molecular and morphological phenotypes in HF itself prompted us to investigate the possibility that the Tcl1 function(s) could be complemented by the expression of other members of the Tcl1 family. Therefore, we initially carried out reverse transcriptase-PCR on wt and Tcl1 À/À RNA samples at 22 days post-depilation, using primers specific for each member of the gene family (Tcl1, and B1 to B5). In this way, we were able to detect the expression of Tcl1B2 gene (Figure 2i ). In particular, when comparing Tcl1 À/À with wt, we observe that Tcl1B2 transcription is also expressed in the former. To better understand whether Tcl1B2 is expressed in those regions with the loss of Tcl1 mRNA, we carried out fluorescence in situ hybridization experiments using a probe specific for Tcl1B2 both on wt and Tcl1 À/À skin samples. We found that this gene is normally expressed in the same regions of the homolog Tcl1, both in wt and Tcl1 À/À early anagen (Figures 2l and m) and in catagen-telogen (not shown). Tcl1B2 is also present along the entire outer root sheath up to the epidermis (not shown). The Tcl1 gene and hair follicle cycling in mice G Ragone et al
The absence of Tcl1 affects proliferation in the HF and differentiation in epidermis The epidermis contains self renewing and proliferating cells, harboring stem-cell properties in the HF and epidermal basal layer compartments (Stenn and Paus, 2001) . The former are able to regenerate a follicle at each cycle and to re-epithelialise the epidermis during wound repair. We then assessed if Tcl1 was involved in proliferative/apoptotic pathways in the skin, after which we used the depilation technique (Chase, 1954; Paus et al., 1990 Paus et al., , 1994a Paus et al., , b, 1999 on wt, Tcl1 À/À and newly generated K14-TCL1; Tcl1 À/À mice, as this allows the synchronization of the HF cycle starting from the beginning of anagen. At day 3-post-depilation we found, in wt mice, a strong Ki67 labeling in the epithelial strand. At this time, this is a growing structure that contains actively proliferating secondary HG-cells, also known as transient amplifying (TA) cells. Ki67 staining during anagen matches exactly with the expression pattern of Tcl1 in catagen-telogen (see arrowheads in Figures 2h and 3a) , with no proliferation taking place in the bulge (Figure 3a) . Moreover, TdT-mediated dUTPdigoxigenin DNA-nick end labeling (TUNEL) þ cells are present in the proximal basal structure of the old degenerating hair (Figure 3a) . In Tcl1 À/À mice, we were not able to detect any Ki67 þ proliferating cells in HF, whereas TUNEL þ cells are present in the old degenerating hair as in wt ( Figure 3b ). As no TUNEL þ cells are present in the HF, these cells do not undergo apoptosis, although they presumably cannot start their proliferative program, being apparently blocked at G1 phase. The proliferative pattern of the secondary HGcells seems to be completely rescued in the K14-TCL1; Tcl1 À/À transgenic mice (Figure 3c ). Thus, these results indicate that Tcl1 is required (provides signal) for the proliferation of the secondary HG-cells.
In the same experiment, the presence of the proliferating basal layer and the degenerating keratinocytes of the cornified layer could be assessed (Figures 3d-f) . early anagen HF (day 3 after depilation), respectively. Green is Tcl1B2 RNA, red is Tcl1, blue is PI nuclear staining; bars: 11.5 mm. Tcl1B2 expression is detectable both in wt and Tcl1 À/À HFs. All the pictures are representative examples.
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Usually in the wt, (Figure 3d ) it is possible to distinguish between the proliferating keratinocytes of the basal layer and the degenerating keratinocytes of the cornified layer. In the Tcl1 À/À mice, in the basal layer (Figure 3e) , it is possible to observe that most of the proliferating cells are also apoptotic, indicating that these mice have a differentiation-proliferation imbalance.
Again, in the K14-TCL1; Tcl1 À/À transgenic mice epidermis, the phenotype seems to be completely rescued, although more cells of the cornified layer seems to undergo apoptosis with respect to the wt epidermis (Figure 3f) . Thus, these results indicate that Tcl1 is required for the correct proliferative-differentiation program of the keratinocytes.
The absence of Tcl1 results in loss of CD34 expression in anagen bulge cells So far, we have shown that Tcl1 is expressed in HF active cell populations, and its absence affects the proliferative rate of these cells in anagen, probably contributing to hair loss, in Tcl1 À/À mice. The earlier observation of the presence of Tcl1 in compartments containing 'stemness' ability prompted us to investigate the expression of Tcl1 in the CD34 þ cells of HF. In anagen, we found that Tcl1 co-localizes with CD34 in the bulge cells in all the observed wt HFs (Figure 4a) ; the absence of Tcl1 is associated with a markedly decreased expression of CD34 itself in the majority (69%) of the examined HFs of Tcl1 À/À mice (Figure 4b ). The expression of CD34 is at least partially (as quantity) rescued in K14-TCL1, Tcl1
À/À mice HFs (Figure 4c) .
No CD34 expression could be assessed at catagentelogen in both Tcl1 À/À and Tcl1 þ / þ mice. This could be owing undetectable expression levels of CD34 in these stages (data not shown).
We did not find any difference in the expression of another marker of 'stemness', a6-integrin, in Tcl1 À/À vs wt animals (not shown).
These results indicate that Tcl1 may play a role in maintaining CD34 þ stem-cell properties in skin HF.
À/À mice show dramatic decrease of BrdU þ cells in the secondary HG and in the bulge To study the in vivo effects of Tcl1 depletion on the proliferation of stem cells (SCs) in HF, we carried out BrdU incorporation assays. It is known that the downregulation of CD34 in bulge cells leads to the loss of stem-cell characteristics, such as slow cycling and Tumbar et al., 2004) . We administered BrdU in vivo to Tcl1 À/À mice to study the cycling of both bulge 'label retaining' SC as well as TA cells in the anagen secondary HG of these mice. This is important also because it is known that at least a subset of TA cells can dedifferentiate and repopulate the bulge SC niche during the very first steps of anagen (Ito et al., 2004) . So far we have described that in Tcl1 À/À mice there is a loss of proliferating Ki67 þ cells (without increasing of TUNEL þ cells) associated to a loss of CD34 þ cells in the bulge: we then tested if this is a consequence of a functional defect of TA cells to enter the cell cycle, after the BrdU incorporation in the HFs during the first 3 days of anagen. We found that, whereas in the wt mice BrdU þ TA cells are diffused throughout the entire secondary HG and are well present in the bulge (Figure 4d ), in the Tcl1 À/À mice BrdU þ TA cells and BrdU þ SC in the bulge are completely lost (Figure 4e) . In a few cases, we were able to find up to 3-4 BrdU þ cells in the bulge, probably because of the residual cells from the hair plucking (Figure 4f ). The number of BrdUÀHFs in Tcl1 À/À is similar to those of CD34À in the same mice described above. Conversely, BrdU incorporation in the secondary HG-cells seems to be completely rescued by the K14-TCL1, Tcl1
À/À transgenic mice (Figure 4g) .
Taken together, all our observations strongly indicate that the expression of Tcl1, in the catagen-telogen transition, contributes to the TA cell to entering the cell cycle and, therefore, in the proliferation and repopulation of the bulge SC niche and finally, in the creation of a new hair cycle.
Discussion
The observation that Tcl1 À/À mice develop a mild but constant and unexpected phenotype in the skin, The Tcl1 gene and hair follicle cycling in mice G Ragone et al prompted us to investigate the potential role of Tcl1 in the epidermis and skin appendages. We found that Tcl1 is expressed in the bulge of the anagen phase and in the secondary HG-cells in the catagen-telogen phase of the HF of wt mice, and in the Tcl1 À/À mice, there is a lack of proliferating cells following synchronization after depilation.
The expression of Tcl1 is very high in the bulge at the anagen stage and to a extent during the catagen-telogen transition in the secondary HG-cells. Lines of evidence support the idea that HF-secondary germ cells have an intrinsic, bulge-region independent, proliferative potential and are directly involved in the early events of HF anagen induction (Cotsarelis et al., 1990; Morris and Potten, 1999; Panteleyev et al., 2001) . Furthermore, no cell migration to the HG from the bulge region has been reported in telogen (Morris and Potten, 1999; Ito et al., 2004) . It has also been shown that the lower portion of the bulge collapses and undergoes gene expression changes, giving origin to the secondary HG-cells in late catagen (and not in telogen-anagen transition), and that these cells are able to dedifferentiate again into bulge cells and repopulate the bulge niche at the beginning of the anagen (Ito et al., 2004) . It is interesting that the expression pattern of Tcl1 strictly follows the events described above ( Figure 5 ).
In anagen, loss of Tcl1 implicates less proliferative activity in the bulge (SC) and secondary HG-cells (TA), as shown by BrdU incorporation and Ki67 labeling. If the expression of Tcl1 is maintained constantly within the same cells, as it seems to be in other tissues such as B cells and embryo, it would implicate that proliferating cells that derive from HG-cells, during catagen-telogen transition, are those starting the new HF cycle and repopulating the bulge ( Figure 5 ). As in the embryo, where Tcl1 is necessary in the first divisions of proliferating cells of the preimplantation embryo, and for self-renewal but not differentiation of their derived ES-cells (Matoba et al., 2006; Galan-Caritad et al., 2007) in the HF, Tcl1 is important very early during the anagen proliferation of secondary HG-cells, as beyond the third day after depilation the expression of Tcl1 is no more detectable.
It is interesting to observe that in wt, CD34 and Tcl1 colocalize in the same cells (SC) and that abrogation of Tcl1 leads to the loss of CD34, and this could be owing to the fact that some of the SC that are repopulating the bulge derive from TA cells as proposed (Ito et al., 2004) . it is also interesting to observe that HFs derived from CD34 À/À mice and Tcl1 À/À mice are blocked at telogen (Trempus et al., 2007) .
All these findings provide a new specific marker for secondary HG-cell population and bulge cells, and definitely place back in time, at late catagen and not in telogen-anagen transition, the commitment status of the former.
We mainly studied Tcl1 phenotype in HFs of Tcl1 À/À mice in those stages in which Tcl1 is expressed in wt mice. Although no apparent major morphological differences are visible between wt and Tcl1 À/À mice HFs, Tcl1 À/À mice develop alopecia, and this alopecia is progressive with the age and affects 100% of the Tcl1 À/À mice. Moreover, in these mice, epidermis in the alopecia area undergoes inflammation, hypertrophy and finally wounds. The observation of the rescue of the alopecia and wounds by simply overexpressing TCL1 into Figure 5 Schematic representation of the HF during the hair cycle. At late catagen, catagen-telogen transition the bulge cells divide and give origin to the secondary hair germ cells. At that time these cells acquire the TA potential. Once induced the anagen (regenerative) phase by depilation, the TA cells start to actively proliferate, giving origin to a new growing structure on one side and, in a small percentage to the repopulation of the bulge SC niche (that were destroyed by depilation) on the other side. Ep: epidermis; HS: hair shaft; apm: arrector pili muscle; Bu: bulge; HG: secondary hair germ; DP: dermal papilla.
The Tcl1 gene and hair follicle cycling in mice G Ragone et al keratinocytes in K14-TCL1; Tcl1 À/À mice indicates that dermal immune infiltrate is the consequence, more than the cause, of the skin impairment. Whether it is owing to problems of the innate immune response (leaded by skin integrity), a higher susceptibility to external agents or simply to intrinsic cellular defects of keratinocytes is the goal of further investigations, even though the rescue of proliferation, CD34 expression and BrdU incorporation in transgenic mice supports the last hypothesis. Here we show that CD34 þ cells are diminished in Tcl1 À/À mice. We do not know if and how Tcl1 regulates CD34 expression; however, it has already been reported that Tcl1 and CD34 are co-expressed in the lymphoid compartment in the very early stage of B-cell differentiation (pro-B cells) (Narducci et al., 2000) , and that this compartment of pro-B cells is also less numerous in the Tcl1 À/À mice (Kang et al., 2005) . Together with the inflammation and hypertrophy, the CD34 þ bulge cell pool derived from the secondary HG-cells dedifferentiation could easily finish and explain the onset and progression of alopecia with age in these mice. It is known that from the bulge arise, among others, those cells involved in epidermal wound repair (Ito et al., 2005; Trempus et al., 2007) . In the absence of secondary HG-cells with proliferative status, bulge cells are progressively lost after some cycles, and this ultimately increases the CD34 þ depletion pool. Tcl1 function is exerted in HF stem and proliferating cells, as its absence affects CD34 expression. The mechanism(s) through which this takes place will be the subject of further investigations. Consequently in Tcl1 À/À mice, we observe a loss of bulge cells and a decreased, if not absent, proliferative rate in early anagen, when a new structure needs to be formed after the wounding stimulus of depilation.
The variability of the skin phenotype could be owing different overlapping or redundancy. Given the high similarity with Tcl1, these genes could act as functional homologs in the HF. In fact, we observed transcriptional levels of Tcl1b2 but not of Tcl1b1, 3, 4 and 5, which were not detectable neither by reverse transcriptase-PCR nor by fluorescence in situ hybridization, both on wt and Tcl1 À/À mice HFs. We were unable, on these mutant mice, to show by immunohistochemistry any direct effect on AKT phosphorylation variation (not shown), although this should not be excluded by observing the role that PI3/Akt signaling exerts in postnatal epidermal development and SC-self renewal, and production of committed cells in hematopoiesis. Work here might be complicated by redundant functions of the family members of Akt1/2/3 and Tcl1 gene family. However, it is interesting to observe that in the epidermis, deletion of Akt1 causes thinner epidermal layers and retarded-HF development, whereas double mutants (Akt1
) (Peng et al., 2003; Yang et al., 2005) show more severe defects, and transgenic mice expressing Akt-Mer fusion proteins induces epidermal hyperplasia and proliferation of epidermal progenitors leading to epidermal and follicular hyperplasia (Murayama et al., 2007) . As already pointed out before, Tcl1 is involved in the normal-self renewal of ES cells (Glover et al., 2006; Matoba et al., 2006; GalanCaritad et al., 2007) and upstream genes such as transcription factor Oct4, which directly activates Tcl1 in ES cells and is expressed in human HFs (Yu et al., 2006) , should also be taken into account.
In conclusion, we show that Tcl1 has a novel, important role in skin homeostasis. This adds to many other hematopoietic factors that are expressed in the HFs: CD34, but also Tcf-3/Lef-1, NFATC1, S100A4, LTBP1, b1-integrin and so on. (Tiede et al., 2007) . We believe that this study may contribute to a better understanding of the cellular mechanisms underlying the physiology of a population of adult stem cells and to the opening of a novel field of study for TCL1 function.
Materials and methods
Animals
Wild type, Tcl1
À/À and K14-TCL1; Tcl1 À/À mice background is C57BL/6NCrlBR (C57BL/6) (Narducci et al., 2002) . K14-hTCL1 transgenic mice was obtained by cloning the human TCL1 cDNA (Bichi et al., 2002) into a pG3Z vector containing a K14 cassette (pG3Z-K14, gift from E Fuchs), with BamHI as insertion site. The plasmid was microinjected into C57BL/ 6NCrlBR (C57BL/6) ES cells at the Thomas Jefferson University Animal Facility at Philadelphia (PA, USA). Founders and pups were genotyped by PCR using the primers: b-globin 1: 5 0 -CTG CTA ACC ATG TTC ATG CC-3 0 and 210 R: 5 0 -GAT CGG TAT CGT CCA TCA GG-3 0 . K14-hTCL1 genotypes into the Tcl1 À/À background also were determined by using the primers: À/À and Tcl1 À/À mice was induced as already described (Chase, 1954; Paus et al., 1990 Paus et al., , 1994a Paus et al., , b, 1999 . Depilated skin was harvested as described (Paus et al., 1999) .
RT-PCR
Total RNA was isolated from back skin samples using TRI-REAGENT protocol (Sigma-Aldrich, St Louis, MO, USA). 3 mg total RNA was used to produce cDNA. Tcl1 was amplified for 40 cycles followed by 40 cycles of nested PCR amplification. Primers used to amplify cDNAs are listed in Supplementary materials.
Immunofluorescence
Sections were fixed in 4% paraformaldehyde and permeabilized with phosphate buffered saline/0.1%TritonX-100. Incubations for 2 h at room temperature with primary antibodies were followed by 1 h incubations with the correspondening secondary antibodies. Blocking was 10% normal goat serum or 3% bovine serum albumin. Nuclei counterstain: 2 mg/ml of propidium iodide (PI) dye. Antibodies used: monoclonal rat anti-Tcl1 (5A4) 1:50 and polyclonal rabbit anti-CD34 1:100 (Santa Cruz Biotechnology Inc., Santa Cruz, CA, USA).
TdT-mediated dUTP-digoxigenin DNA-nick end labeling was carried out using the in situ cell death detection, POD (Roche Corp., Indianapolis, IN, USA), according to the manufacturer's protocol, followed by Ki67 immunodetection using a rabbit antiserum 1:1500 (Novocastra Labs Ltd., Newcastle upon Tyne, UK). Fluorescein isothiocyanate (FITC)-or CY5-conjugated anti-rat, anti-rabbit or anti-goat IgG was obtained from Jackson ImmunoResearch Laboratories Inc. (West Grove, PA, USA). The specimens were observed by laser scanning confocal microscopy using a Zeiss LSM 510 Meta microscope. The experiments were carried out twice on different mice (males and females).
Immunohistochemistry
Incubation for 2 h at room temperature with rat anti-Tcl1 primary antibody 5A4 (Narducci et al., 2002) 1:50 was carried out after fixation in 4% paraformaldehyde and permeabilization with phosphate buffered saline/0.1%TritonX-100. Endogenous peroxidase was blocked with 0.3% hydrogen peroxide in methanol followed by 1 h incubation with biotinylated rabbit anti-rat IgG 1:200 and 15 0 incubation with horseradish peroxides-streptavidin (LSAB system, DAKO Corp., Glostrup, DK). Staining was carried out with 3-3 0 diamino benzidine reaction and counterstaining with hematoxylin. Giemsa and hematoxylin-eosin experiments were carried out following standard procedures. The experiments were carried out twice on different mice (males and females).
In situ hybridization
The 249 bp mouse Tcl1B2 cDNA obtained by PCR was subcloned into pCRII. FITC labeled RNA probes were synthesized with SP6 and T7 RNA polymerases, according to the manufacturer's instructions (Roche).
Hybridizations were carried out at 56 1C O/N after 4% paraformaldehyde fixation and 0.1 M triethanolammine/0.25% acetic anhydride post-fixation. Then O/N incubation at 4 1C with a rabbit anti-FITC 1:100 (Zymed Inc., San Francisco, CA, USA) was carried out followed by a 4 h incubation at room temperature with a FITC-conjugated goat anti rabbit IgG. Nuclei were counterstained with PI dye. Sense strands were used as negative controls. Acquisitions and number of experiments are those as indicated above.
BrdU labeling and detection 8-weeks-old C57BL/6NCrlBR wt, Tcl1 À/À and K14-TCL1; Tcl1 À/À mice were plucked as mentioned. At 24 h later, the mice were subcutaneously injected with BrdU (50 mg/g body weight) twice daily for 4 days. Three days after plucking the dorsal skins were excised, embedded in OCT and frozen.
Sections were fixed with 30 ml of 50 mM glycine added to 70 ml of absolute ethanol, pH 2.0 for 20 min at À20 1C, washed with phosphate buffered saline and incubated with an antiBrdU working solution (Roche) containing nucleases. Animal research kits were used (DAKO Corp., Glostrup, DK). The sections were incubated with 1:50 diluted FITC-conjugated streptavidin (Vector Labs, Burlingame, CA, USA) for 30 min at room temperature; nuclei were counterstained using PI dye. Acquisitions and number of experiments were those as indicated above.
Abbreviations HF, hair follicle; ORS, outer root sheath; SC, stem cells TA, transient amplifying; TCL1, T-cell leukemia/lymphoma 1.
